Latest Financial Position News

Argent BioPharma has secured a transformative acquisition of AusCann’s core assets, bolstering its drug delivery technology and manufacturing capabilities ahead of a planned U.S. listing. The company also reported key clinical milestones and refinancing moves in its September 2025 quarterly update.

NT Minerals has completed the sale of its Redbank/Wollogorang Copper Project to Golden Horse Minerals, receiving $1 million in cash plus shares valued at $3.4 million. The company now faces a tight cash position while reviewing new mineral projects.

Strike Resources advances its high-grade Apurímac Iron Ore Project amid political upheaval in Peru, while its Lithium Energy stake pushes forward with key acquisitions and exploration despite ASX suspension.

TasFoods reports a 13.2% revenue decline in Q3 2025 driven by oversupply and discounting in the Tasmanian poultry market, while advancing a $2 million sale of Pyengana Dairy and reducing debt through property sales.

Resources & Energy Group Limited (REZ) has secured approval to expand gold vat leach production at its East Menzies Gold Project, transitioning from trial to commercial scale. The company also announced a maiden JORC 2012 Inferred Mineral Resource at Gigante Grande, underpinning future growth.

PARKD Limited has raised $1 million to fund its East Coast expansion, secured a new prefabrication facility in NSW, and landed its first pilot project with McNab Group, marking a pivotal step in its national rollout.

Tinybeans Group Limited reports steady subscription revenue and improved cash flow in Q1 FY26, while launching a new iOS Photo Store to diversify income streams and enhance user monetisation.

OzAurum Resources reports strong drilling results at its Mulgabbie North Gold Project and regains full control of its Feasibility Study, positioning the company for accelerated development amid record gold prices.

Evolution Energy Minerals has successfully raised A$1.75 million through a fully underwritten rights issue, accelerating its Chilalo Graphite Project timeline to first ore production by October 2027. The company is also advancing exploration at its Chikundo copper project while streamlining operations.

Tryptamine Therapeutics has initiated the world’s first clinical trial of its IV-infused psilocin drug, TRP-8803, targeting Binge Eating Disorder, alongside a pioneering EEG biomarker collaboration and new funding.

Alice Queen Limited has reported significant progress at its Viani Fiji Project, extending high-grade gold mineralisation over a 5km strike. The company also registered a mining lease application for its Horn Island Project and raised $1 million via convertible notes to fund ongoing exploration.

Challenger Gold Limited advances its Hualilan Gold Project with commissioning of the Casposo Toll Milling plant and key operational contracts, while Ecuador projects gain value following Lumina Gold’s takeover. A $30 million placement strengthens funding for upcoming milestones.